Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele: Comparison to confirmed Alzheimer's disease patients

Journal of the Neurological Sciences

Volumn 138, Issue 1-2, 1996, Pages 97-104

  Sparks, D Larry ^a,b,d   Scheff, Stephen W ^a   Liu, Huaichen ^a   Landers, Teresa ^a   Danner, Fred ^c   Coyne, Carolyn M ^b,d   Hunsaker III, John C ^a,b,d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d C 439 Transplant CenterUniversity   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E genotype; Coronary artery disease; Hypertension; Neurofibrillary tangle density; Non demented control; Senile plaque density

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 0030002516     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(96)00008-1     Document Type: Article

References (51)

1. Agbayewa, M. (1986) Earlier psychiatric morbidity in patients with Alzheimer's disease. J Am Geriatr Soc 34: 561-564.
2. Amouyel, P., T. Brousseau, J.-C. Fruchart and J. Dallongeville (1993) (Letter). Lancet 342: 1309.
3. Aronson, M.K., W.L. Ooi, H. Morgenstern, A. Hafner, D. Masur, H. Crystal, W.H. Frishman, D. Fisher and R. Katzman (1990) Women, myocardial infarction, and dementia in the very old. Neurology 40: 1102-1106.
4. Boerwinkle, E. and C.F. Sing (1987) The use of measured genotype information in the analysis of quantitative phenotypes in man. Ann Hum Genet 51: 211-226.
5. Breteler, M.M., J.J. Claus, D.E. Grobbee and A. Hofman (1994) Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam study. Br Med J 308: 1604-1608.
6. Corder, E.H., A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines and M.A. Pericak-Vance (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
7. Couderc, R., F. Mahieux, S. Bailleul, G. Fenelon, R. Mary and J. Fermanian (1993) Prevalence of apolipoprotein E phenotype in ischemic cerebrovascular disease: A case-control study. Stroke 24: 661-664.
8. Czech, C., H. Forstl, F. Hentschel, U. Monning, C. Bestorn, C. Geiger-Kabisch, H. Sattel, C. Masters and K. Beyreuther (1994) Apolipoprotein E-4 gene dose in clinically diagnosed Alzheimer's disease: Prevalence, plasma cholesterol levels and cerebrovascular change. Eur Arch Psychiatry Clin Neurosci 243: 291-292.
9. Czech, C., U. Monning, P.J. Teinari, T. Hartmann, C. Masters and K. Beyreuther (1993) (Letter). Lancet 342: 1309-1310.
10. Davignon, J., R.E. Gregg and C.F. Sing (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1-21.
11. Frisoni, G.B., A. Bianchetti, S. Govoni, M. Trabucchi, L. Calabresi and G. Franceschini (1994) Association of apolipoprotein E4 with vascular dementia. J. Am. Med. Assoc. 271: 1317.
12. Gregg, R.E., L.A. Zech, C. Cabelli and H.B. Brewer (1989) Apolipoprotein E modulates the metabolism of apolipoprotein B containing lipoproteins by multiple mechanisms. Cholesterol Transport Systems and Their Relation to Atherosclerosis. Berlin/Heidelberg, Germany, Springer-Verlag. 11-21.
13. Gregg, R.E., L.A. Zech, E.J. Schaefer, D. Stark, D. Wilson and H.B. Brewer (1986) Abnormal in vivo metabolsim of apolipoprotein E4 in Humans. J Clin Invest 78: 815-821.
14. Hixson, J.E. and D.T. Vernier (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545-548.
15. Khachaturian, Z. (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42: 1097-1105.
16. Kurosawa, H., Y. Shimizu, Y. Nishimatsu, S. Hirose and T. Takans (1983) The relationship between mental disorders and physical severities in patients with acute myocardial infarction. Jpn Circ J 47: 723-728.
17. Kuusisto, J., K. Koivisto, K. Kervinen, L. Mykkanen, E.-L. Helkala, M. Vanhanen, T. Hanninen, K. Pyorala, Y.A. Kesaniemi, P. Riekkinen, et al. (1994) Association of apolipoprotein E phenotypes with late ounset Alzheimer's disease: Population based study. Br Med J 309: 636-638.
18. Lehtonen, A. and S. Luutonen (1986) High-density lipoprotein cholesterol levels of very old people in the diagnosis of dementia. Age Ageing 15: 267-270.
19. Lucotte, G., F. David, S. Visvikis, B. Leininger-Muller, G. Siest, M.C. Babron and R. Couderc (1993) (Letter). Lancet 342: 1309.
20. Mahley, R.W. (1988) Apolipoprotein E: Cholesterol transport protein with expanded role in cell biology. Science 240: 622-630.
21. Mayeux, R., Y. Stern, R. Ottman, T. K. Tatemichi, M.-X. Tang, G. Maestre, C. Ngai, B. Tycko and H. Ginsberg (1993) The apolipoprotein E4 allele in patients with Alzheimer's disease. Ann Neurol 34: 752-754.
22. Metter, E.J. and R.S. Wilson (1993) Vascular Dementias. New York, Oxford University Press.
23. Nagy, Z., M.M. Esiri, K.A. Jobst, J.H. Morris, E.M.-F. King, B. McDonald, S. Litchfield, A. Smith, L. Barnetson and A.D. Smith (1995) Relative roles of plaques and tangles in the dementia of Alzheimer's Disease: Correlations using three sets of neuropathological criteria. Dementia 6: 21-31.
24. Nalbantoglu, J., B. M. Gilfix, P. Bertrand, Y. Robitaille, S. Gauthier, D.S. Rosenblatt and J. Poirier (1994) Predictive value of apolipoprotein E genotypeing in Alzheimer's disease: Results of an autopsy series and an analysis of several combined studies. Ann Neurol 36: 889-895.
25. Namba, Y., M. Tomonaga, H. Kawasaki, E. Otomo and K. Ikeda (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeld-Jakob disease. Brain Res 541: 163-166.
26. Poirier, J., J. Davignon, D. Bouthillier, S. Kogan, P. Bertrand and S. Gauthier (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697-699.
27. Prince, M., M. Cullen and A. Mann (1994) Risk factor for Alzheimer's disease and dementia: A case-control study based on the MRC elderly hypertension trial. Neurology 44: 97-104.
28. Rebeck, G.W., J.S. Reiter, D.K. Strickland and B.T. Hyman (1993) Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 11: 575-580.
29. Reich., P., Q. Regestein, B. Murawski, R. DeSilva and B. Lown (1983) Unrecognized organic mental disorders in survivors of cardiac arrest. Am J Psychiatry 140: 1194-1197.
30. Roses, A.D. (1994) Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 53: 429-437.
31. Saunders, A.M., W.J. Strittmatter, D. Schmechel, P.H. St. George, M.A. Pericak-Vance, S.H. Joo, J.F. Gusella, D.R. Crapper-MacLachlan, J. Growden, M.J. Alberts, et al. (1993) Association of apolipoprotein E allele e4 with late-onset familial and sporatic Alzheimer's disease. Neurology 43: 1467-1472.
32. Sing, C.F. and J. Davignon (1985) Role of apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37: 268-285.
33. Sparks, D., F. Danner, D. Davis, C. Hackney, T. Landers and C. Coyne (1993a) Neurochemical and histopathologic alterations characteristic of Pick's disease in a non-demented individual. J Neuropathol Exp Neurol 53: 37-42.
34. Sparks, D.L. (1995) Intraneuronal β-amyloid (βA4) immunoreactivity in the CNS. Neurobiol Aging: in press.
35. Sparks, D.L., J.C. Hunsaker, S.W. Scheff, R.J. Kryscio, J.L. Henson and W.R. Markesbery (1990) Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging 11: 601-607.
36. Sparks, D.L., H. Liu, D.R. Gross and S.W. Scheff (1995b) Increased density of cortical apolipoprotein E immunoreactive neurons in rabbit brain after dietary administration of cholesterol. Neurosci Lett 187: 142-144.
37. Sparks, D.L., H. Liu, S.W. Scheff, C.M. Coyne and J.C. Hunsaker III (1993b) Temporal sequence of plaque formation in the cerebral cortex of non-demented individuals. J Neuropathol Exp Neurol 52: 135-142.
38. Sparks, D.L., S. W. Scheff, J.C. Hunsaker III, H. Liu, T. Landers and D.R. Gross (1994) Induction of Alzheimer-like β-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 126: 128-134.
39. Sparks, D.L., S.W. Scheff, H. Liu, T. Landers, C.M. Coyne and J.C. Hunsaker (1995b) Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurological Sci 131: 162-167.
40. Strittmatter, W., A. Saunders, D. Schmeckel, M. Pericak-Vance, J. Enghild, G.S. Salvesen and A.D. Roses (1993) Apolipoprotein E: High affinity binding to beta-amyloid and increased frequency of type-4 allele in late-onset familial Alzheimer's. Proc Natl Acad Sci (USA) 90: 1977-1981.
41. Strittmatter, W.J., A.M. Saunders and M. Goedert (1994) Isoform specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer's disease. Proc Natl Acad Sci (USA) 91: 11183-11186.
42. Tresch, D., M. Folstein, P. Robins and W. Hazzard (1985) Prevalence and significance of cardiovascular disease and hypertension in elderly patients with dementia and depression. J Am Geriatr Soc 33: 530-537.
43. Utermann, G., I. Kindermann, H. Kaffarnik and A. Steinmetz (1984) Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet 65: 232-236.
44. Warden, B.A. and E. Thompson (1994) Apolipoprotein E and the development of atherosclerosis. Laboratory Med 25: 449-455.
45. Weisgraber, K.H. (1994) Apolipoprotein E: Structure-function relationships. Advances in protein chemistry. Academic Press, Inc. 249-302.
46. Wilkie, F. and C. Eisdorfer (1971) Intelligence and blood pressure in the aged. Science 172: 959-962.
47. Wilson, P.W.F. (1995) Relation of high-density lipoprotein subfractions and apolipoprotein E isoforms to coronary disease. Clin Chem 41: 165-169.
48. Wilson, P.W.F., R.H. Myers, M.G. Larson, J.M. Ordovas, P.A. Wolf and E.J. Schaefer (1994) Apolipoprotein E alleles. dyslipidemia and coronary heart disease. JAMA 272: 1666-1671.
49. Wolf, P.A., R.B. D'Agostino, A.J. Belanger and W. B. Kannel (1991) Probability of Stroke: A risk profile for the Faminghan Study. Stroke 22: 312-318.
50. Yoshizawa, T., K.K. Yamakawa, Y. Komatsuzaki, T. Arinami, E. Ohuni and H. Mizusawa (1994) Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer's disease. Ann Neurol 36: 656-659.
51. Zhang, S.H., R.L. Reddick, J.A. Piedrahita and N. Maeda (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-471.